Form D · Biotechnology

KINEMED INC

Emeryville, CA · CIK 0001167058

Offering snapshot reported Jul 24, 2015 · SEC filing

Reported sold
$2.15M
Offering amount: $12.5M
Investors reported
40
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 11, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.07M$2.15MJun 26, 2015: $1,699,235.00Jun 26, 2015Jul 24, 2015: $2,149,235.00Jul 24, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,699,235 → $2,149,235
  • Reported investors32 → 40

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 24, 2015Amendment$2,149,235$450,000vs Jun 26, 201540SEC filing
Jun 26, 2015Initial$1,699,235No comparison32SEC filing
Jan 13, 2014Amendment$8,400,004$6,442,287vs Aug 22, 2013131SEC filing
Aug 22, 2013Initial$1,957,717No comparison43SEC filing
Dec 13, 2012Initial$1,039,850No comparison25SEC filing
Nov 10, 2011Amendment$3,750,000$1,934,654vs Sep 2, 201178SEC filing
Sep 2, 2011Initial$1,815,346No comparison56SEC filing
Jan 8, 2010Amendment$5,547,786$801,766vs Nov 23, 2009127SEC filing
Nov 23, 2009Amendment$4,746,020$538,500vs Sep 2, 2009121SEC filing
Sep 2, 2009Initial$4,207,520No comparison113SEC filing
Apr 28, 2006PaperNot reportedNo comparisonNot reported

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$96.1K
Finders' fees
$0
Form D file number
021-242589

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Feltl and Company, Inc.6905

Source: Form D, filed Jul 24, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James E. Burden Director
Charles J. Casamento Director
Robert K Curry Director
Robert K Cury Director
Patrick J. Doyle Director, Executive
David M Fineman Director, Executive
Marc Hellerstein Director
K. Peter Hirth Director
Matthew M Loar Executive
James S.J. Manuso Director
Edward Neugeboren Director
Henry C. Settle, Iii Director
Henry Settle Jr. Director
Robert B. Stein Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5980 Horton Street, #470
Emeryville, CA, 94608